Koers OWC Pharmaceutical Research Corp.
Aandelen
OWCP
US67109N1081
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% | -.--% | -.--% |
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 15,37 mln. 14,23 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -4 mln. -3,7 mln. | Nettowinst (verlies) 2018 | -10 mln. -9,26 mln. | EV/omzet 2017 | - |
Nettoliquiditeiten 2017 | 971K 899K | Nettoliquiditeiten 2018 | 3,46 mln. 3,21 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-14,5
x | K/w-verhouding 2018 |
-1,21
x | Werknemers | 9 |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 16-06-14 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 02-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 25-06-20 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 497 | |
-26,77% | 16,48 mld. | |
-43,46% | 2,79 mld. | |
+22,46% | 1,94 mld. | |
-12,32% | 1,46 mld. | |
+31,49% | 1,33 mld. | |
-16,15% | 966 mln. | |
+1,33% | 791 mln. | |
-31,07% | 788 mln. | |
-25,95% | 620 mln. |